Home / Critical illness cover / - HIV or AIDS from Occupational Duties or Accident
Background information
By the end of 2001, more than 48,000 people had been diagnosed HIV-positive.
Over the same period, over 12,000 had died with AIDS.
In addition, it is estimated that there are currently more than 11,000 people living with HIV - unaware of being HIV-positive.
While the number of people dying from AIDS is falling (due to the widespread introduction of 'combination therapy' in 1996), the number of people living with HIV is set to increase by 47% between 2000 and 2005.
(Terrence Higgins Trust, 2002)
Definition
Infection by HIV or AIDS provided:
- the infection results directly from occupational duties or accidental exposure involving involuntary contact with either:
- a hypodermic needle or an infected sharp instrument; or
- a person infected with HIV;
- the incident happens in the European Union, The Channel Islands or The Isle of Man after the cover start date;
- within five days, the incident is recorded as having been reported:
- according to the procedures of the relevant occupation;
- to a GP; or to the police, and
- a test, showing no HIV or HIV antibodies, is made within five days of the incident and a later test is made within 12 months showing infection by HIV or AIDS.
What does this mean?
Any incident which takes place whilst performing occupational duties, or any accident at work or elsewhere which leads to infection with the HIV virus would be covered. A claim would be paid out if, in conjunction with the procedures outlined above, it is proved that infection with HIV was a result of occupational duties or an accident. Note that this condition is not restricted to the emergency services – all occupations are covered.
06 August 2008 17:27:22
An antibiotic developed from maggots may be used to fend off different types of bacteria including certain types of the deadly methicillin-resistant Staphylococcus aureus (MRSA), Fox news reported.
Students from Swansea undertook the study and they believe that maggots may now be used to fight superbug infections in hospitals.
Those with life insurance policies maybe interested to know that the team developed a drug called Seraticin that is made from secretions of green bottle fly larvae.
They now believe that they may be able to tackle up to 12 strains of the superbug and that it could be effective against E.coli and C.diff.
Live maggots have recently been used on patient's wounds to help fight MRSA by eating dead tissue, the Mirror reported.
UK life insurance policyholders have learnt that new research from the US has found that patients who are carrying MRSA for long periods of time are at an increased risk of infection and death.
06 August 2008 17:22:31
Those without life insurance policies will be pleased to hear about a proposed program that involves vaccinating children against flu in order to provide protection for the rest of the population.
Whilst the Daily Mail claimed that running the programme could cut flu infection rates by 70 per cent, the Daily Telegraph reported that "flu could be virtually wiped out if all under 16s were vaccinated against the disease".
A similar programe was considered and subsequently rejected in 2006 by the Joint Committee on Vaccinations and Immunisation, the NHS reported.
New research published in the Lancet this week suggested that the influenza vaccine did not provide as much protection as was previously thought.
In the study a group of 3,500 individuals were tested and it was uncovered that in those over 65 there was no link between the flu vaccination and the risk of those people contracting pneumonia.
UK life insurance provides cover in case of injury or illness.
05 August 2008 17:34:54
Those with and without life insurance policies may be interested to know that a trial of a vaccine for HIV patients which allows them to take breaks from their regular medication is planned, the BBC reported.
The trial, which was announced at the Aids 2008 conference in Mexico City, will involve 345 patients in both the US and Europe and the results are due by the end of 2009.
It is hoped that the vaccine could help alleviate side effects associated with the drugs currently used to treat the virus and may help delay the emergence of strains of HIV that are resistant to the drugs.
Dr Barry Peters, of Kings College London, who is leading the research in the UK, said: "A successful immunotherapeutic HIV vaccine would give patients and doctors enormous advantages over current treatments, both in developed and developing countries."
Whilst Dr Peters has qualified that the vaccine being trialled is not the "complete answer", it could go some way to helping produce a "full" vaccine.
UK life insurance provides policy holders with cover in case of illness or injury.
